6 Amendments of Luke Ming FLANAGAN related to 2017/2951(RSP)
Amendment 36 #
Paragraph 7
7. Recalls the importance of transparency in building and maintaining public trust in medicines; recommends in that vein the importance a) of commissioning independent trials and studies of all vaccinations, and b) publication of the results of those trials and studies;
Amendment 55 #
Paragraph 12
12. Condemns the spread of unreliable, misleading and unscientific information on vaccination aggravated by media controversies; calls on Member States and the Commission to take effective steps against the spread of such misinformationcounter the spread of such misinformation by publishing the results of any and all independent studies verifying the effectiveness of the most controversial vaccines, and to further develop awareness and information campaigns, especially for parents, including the creation of a European platform aimed at increasing vaccination coverage;
Amendment 61 #
Paragraph 13
13. Is concerned about the high prices of somemany life-saving vaccines and condemns this profiteering from misery; calls on the Commission and the Member States to implement the measures called for in the European Parliament’s report of 14 February 2017 on EU options for improving access to medicines;
Amendment 68 #
Paragraph 14
14. Is concerned that high vaccine prices disproportionately affect low and middle income countries, including countries that are losing donor support through Gavi, the Vaccine Alliance; calls on the Commission and Member States to take measures to help facilitate cheap access to vaccines in those countries;
Amendment 82 #
Paragraph 17
17. Calls on the Member States and on the Commission to promote awareness- raising campaigns among physicians who provide vaccinations, underlining their obligations, including providing patients (or patients’ legal guardians) with sufficient information about recommended vaccines so that they can make an informed decision;
Amendment 91 #
Paragraph 19
19. Calls on the Commission to facilitate a more harmonised schedule for vaccination across the EU, to share best practice, ensure even coverage across Europe and reduce costs and health inequalities;